DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG)

This publication has 24 references indexed in Scilit:

• Congenital Disorders of Glycosylation
  Annual Review of Genomics and Human Genetics, 2001
• Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations
  Human Genetics, 2001
• Diversity of congenital disorders of glycosylation
  The Lancet, 2001
• Congenital disorders of glycosylation: genetic model systems lead the way
  Trends in Cell Biology, 2001
• High Residual Activity of PMM2 in Patients’ Fibroblasts: Possible Pitfall in the Diagnosis of CDG-Ia (Phosphomannomutase Deficiency)
  American Journal of Human Genetics, 2001
• A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases
  Journal of Medical Genetics, 2001
• Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)
  Human Mutation, 2000
• Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis
  Annals of Neurology, 2000
• Congenital Disorder of Glycosylation-Ic: Case Report and Genetic Defect
  Neuropediatrics, 2000
• A mutation in the human ortholog of theSaccharomyces cerevisiae ALG6gene causes carbohydrate-deficient glycoprotein syndrome type-Ic
  Proceedings of the National Academy of Sciences, 1999